Literature DB >> 3930326

Activation of aldose reductase from human tissues.

B Das, S K Srivastava.   

Abstract

Human aorta, brain, and muscle aldose reductase, partially purified by DEAE-cellulose (DE-52) column chromatography, is activated 2-2.5-fold on incubation with 10 microM each of glucose-6-phosphate, NADPH, and glucose for 20 min at 25 degrees C. The activation of the enzyme was established by following the NADPH oxidation as well as the sorbitol formation using glucose as substrate. The activated form of aldose reductase exhibited monophasic kinetics with glucose and glyceraldehyde, whereas the unactivated or native enzyme exhibited a biphasic kinetics with both the substrates. The activated enzyme was less susceptible to inhibition by aldose reductase inhibitors such as sorbinil, alrestatin, and quercetrin as compared with the unactivated enzyme. Similarly, the native enzyme was strongly inhibited by some of the phosphorylated intermediates of glycolytic pathway, such as 3-phosphoglycerate, 1,3-diphosphoglycerate, 2,3-diphosphoglycerate, and ADP, whereas the activated enzyme was either not inhibited or inhibition was 20-30% only. Partially purified aldose reductase from the normal human lens exhibited properties similar to the native enzyme of other tissues, whereas the enzyme from clear lens obtained from diabetic subjects with severe hyperglycemia expressed properties similar to the in vitro activated enzyme of aorta, brain, and muscle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930326     DOI: 10.2337/diab.34.11.1145

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

3.  Kinetics of carbonyl reductase from human brain.

Authors:  K M Bohren; J P von Wartburg; B Wermuth
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

4.  Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose.

Authors:  A Bakillah; A M Grigorova-Borsos; R Guillot; P Urios; M Sternberg
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

5.  The role of Cys-298 in aldose reductase function.

Authors:  Ganesaratnam K Balendiran; Michael R Sawaya; Frederick P Schwarz; Gomathinayagam Ponniah; Richard Cuckovich; Malkhey Verma; Duilio Cascio
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

6.  Identification of a renal-specific oxido-reductase in newborn diabetic mice.

Authors:  Q Yang; B Dixit; J Wada; Y Tian; E I Wallner; S K Srivastva; Y S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

7.  Galactose ingestion increases vascular permeability and collagen solubility in normal male rats.

Authors:  K Chang; M Tomlinson; J R Jeffrey; R G Tilton; W R Sherman; K E Ackermann; R A Berger; T J Cicero; C Kilo; J R Williamson
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 8.  The effect of oxidants on biomembranes and cellular metabolism.

Authors:  S K Srivastava; N H Ansari; S Liu; A Izban; B Das; G Szabo; A Bhatnagar
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

9.  Thermal stress and diabetic complications.

Authors:  Y Ohtsuka; N Yabunaka; I Watanabe; H Noro; H Fujisawa; Y Agishi
Journal:  Int J Biometeorol       Date:  1995-01       Impact factor: 3.787

Review 10.  Fructose metabolism and metabolic disease.

Authors:  Sarah A Hannou; Danielle E Haslam; Nicola M McKeown; Mark A Herman
Journal:  J Clin Invest       Date:  2018-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.